Announcement of launch, break or close-out of marketing of a medicinal product

The database includes reports since 31st December 2007, date of effect of the Act No 378/2007 Coll., stipulating the obligation of marketing authorisation holders to report launch, suspension or withdrawal from the market of a medicinal product to SÚKL

Search

 

   

   

Number of records: 6
SÚKL code Name of medicinal product Supplement of name Type of announcement Effective date Alternate medicines 1)
Estimated renewal date Reason for interruption/cessation of marketing
0020461 AMBROSAN KAPKY 7,5MG/ML POR GTT SOL 1X100ML Cessation of marketing 17.10.2018 0058374
Commercial/marketing reasons
0020461 AMBROSAN KAPKY 7,5MG/ML POR GTT SOL 1X100ML Interruption of marketing 30.07.2015 0058374
0020461 AMBROSAN KAPKY 7,5MG/ML POR GTT SOL 1X100ML Resumption of marketing 26.10.2011
0020461 AMBROSAN KAPKY 7,5MG/ML POR GTT SOL 1X100ML Interruption of marketing 29.08.2011 0058374
0020460 AMBROSAN KAPKY 7,5MG/ML POR GTT SOL 1X50ML Interruption of marketing 08.12.2010 0107937, 0020461, 0058374
0020460 AMBROSAN KAPKY 7,5MG/ML POR GTT SOL 1X50ML Cessation of marketing 08.12.2010 0020461, 0058374
1) The review shows only medicinal products with active incidence on the Czech market (based on regular reports of supplies of distributed human medicinal products in the previous quarter).

Medicinal products reimbursed from health insurance are marked in color.
Last database update: 22. October 2019 v 01:15